US Stock MarketDetailed Quotes

Edesa Biotech (EDSA)

Watchlist
  • 16.300
  • -1.130-6.48%
Close May 8 16:00 ET
  • 17.050
  • +0.750+4.60%
Post 20:01 ET
144.84MMarket Cap-15.23P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Edesa Biotech (EDSA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2025
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
40.15%2.24M
12.84%7.13M
129.85%2.22M
1.43%1.72M
-17.21%1.59M
-8.01%1.6M
-26.91%6.32M
-45.93%967.18K
-17.83%1.7M
-20.50%1.92M
Selling and administrative expenses
38.43%1.22M
2.66%4.24M
38.22%1.24M
-6.81%964.68K
10.58%1.15M
-23.77%878.87K
-6.67%4.13M
-36.42%900.53K
-0.33%1.04M
9.63%1.04M
-General and administrative expense
38.43%1.22M
2.66%4.24M
38.22%1.24M
-6.81%964.68K
10.58%1.15M
-23.77%878.87K
-6.67%4.13M
-36.42%900.53K
-0.33%1.04M
9.63%1.04M
Research and development costs
10.29%1.12M
27.30%3.67M
1,079.92%1.23M
4.65%939.07K
-58.83%484.31K
44.77%1.02M
-39.89%2.88M
-89.11%103.87K
-12.51%897.31K
-19.33%1.18M
Other operating expenses
65.99%-102.43K
-12.26%-783.89K
-564.11%-247.15K
22.41%-183.28K
82.81%-52.27K
-149.26%-301.2K
-20.18%-698.28K
---37.22K
---236.23K
---304K
Operating profit
-40.15%-2.24M
-12.84%-7.13M
-129.85%-2.22M
-1.43%-1.72M
17.21%-1.59M
8.01%-1.6M
26.91%-6.32M
45.93%-967.18K
17.83%-1.7M
20.50%-1.92M
Net non-operating interest income expense
-97.18%47
-98.33%2.56K
-99.67%55
-98.26%572
-99.39%265
-97.27%1.67K
-47.04%153.5K
-77.08%16.49K
-60.31%32.85K
-49.61%43.19K
Non-operating interest income
-97.18%47
-98.33%2.56K
-99.67%55
-98.26%572
-99.39%265
-97.27%1.67K
-47.04%153.5K
-77.08%16.49K
-60.31%32.85K
-49.61%43.19K
Other net income (expense)
59.12%-8.76K
-849.79%-59.61K
53.22%-5.32K
-510.91%-29.57K
-125.85%-3.3K
-659.21%-21.43K
71.13%-6.28K
-210.07%-11.36K
-40.28%-4.84K
246.76%12.75K
Gain on sale of security
59.12%-8.76K
-183.29%-59.61K
53.22%-5.32K
-510.91%-29.57K
-63.28%-3.3K
-659.21%-21.43K
3.22%-21.04K
-210.07%-11.36K
-40.28%-4.84K
76.77%-2.02K
Other non- operating income (expenses)
----
----
----
----
----
----
--14.77K
--0
----
--14.77K
Income before tax
-38.98%-2.25M
-16.46%-7.18M
-131.63%-2.23M
-4.87%-1.75M
14.56%-1.59M
3.65%-1.62M
26.33%-6.17M
44.08%-962.05K
15.96%-1.67M
20.27%-1.86M
Income tax
0.00%800
0
0
0.00%800
0.00%800
0
0
0.00%800
Net income
-38.98%-2.25M
-16.46%-7.19M
-131.63%-2.23M
-4.87%-1.75M
14.55%-1.59M
3.65%-1.62M
26.32%-6.17M
44.08%-962.05K
15.96%-1.67M
20.26%-1.86M
Net income continuous Operations
-38.98%-2.25M
-16.46%-7.19M
-131.63%-2.23M
-4.87%-1.75M
14.55%-1.59M
3.65%-1.62M
26.32%-6.17M
44.08%-962.05K
15.96%-1.67M
20.26%-1.86M
Minority interest income
Net income attributable to the parent company
-38.98%-2.25M
-16.46%-7.19M
-131.63%-2.23M
-4.87%-1.75M
14.55%-1.59M
3.65%-1.62M
26.32%-6.17M
44.08%-962.05K
15.96%-1.67M
20.26%-1.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-38.98%-2.25M
-16.46%-7.19M
-131.63%-2.23M
-4.87%-1.75M
14.55%-1.59M
3.65%-1.62M
26.32%-6.17M
44.08%-962.05K
15.96%-1.67M
20.26%-1.86M
Basic earnings per share
41.67%-0.28
34.20%-1.27
-10.34%-0.32
51.92%-0.25
48.28%-0.3
11.11%-0.48
34.13%-1.93
48.21%-0.29
23.53%-0.52
29.27%-0.58
Diluted earnings per share
41.67%-0.28
34.20%-1.27
-10.34%-0.32
51.92%-0.25
48.28%-0.3
11.11%-0.48
34.13%-1.93
48.21%-0.29
23.53%-0.52
29.27%-0.58
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Dec 31, 2025(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 40.15%2.24M12.84%7.13M129.85%2.22M1.43%1.72M-17.21%1.59M-8.01%1.6M-26.91%6.32M-45.93%967.18K-17.83%1.7M-20.50%1.92M
Selling and administrative expenses 38.43%1.22M2.66%4.24M38.22%1.24M-6.81%964.68K10.58%1.15M-23.77%878.87K-6.67%4.13M-36.42%900.53K-0.33%1.04M9.63%1.04M
-General and administrative expense 38.43%1.22M2.66%4.24M38.22%1.24M-6.81%964.68K10.58%1.15M-23.77%878.87K-6.67%4.13M-36.42%900.53K-0.33%1.04M9.63%1.04M
Research and development costs 10.29%1.12M27.30%3.67M1,079.92%1.23M4.65%939.07K-58.83%484.31K44.77%1.02M-39.89%2.88M-89.11%103.87K-12.51%897.31K-19.33%1.18M
Other operating expenses 65.99%-102.43K-12.26%-783.89K-564.11%-247.15K22.41%-183.28K82.81%-52.27K-149.26%-301.2K-20.18%-698.28K---37.22K---236.23K---304K
Operating profit -40.15%-2.24M-12.84%-7.13M-129.85%-2.22M-1.43%-1.72M17.21%-1.59M8.01%-1.6M26.91%-6.32M45.93%-967.18K17.83%-1.7M20.50%-1.92M
Net non-operating interest income expense -97.18%47-98.33%2.56K-99.67%55-98.26%572-99.39%265-97.27%1.67K-47.04%153.5K-77.08%16.49K-60.31%32.85K-49.61%43.19K
Non-operating interest income -97.18%47-98.33%2.56K-99.67%55-98.26%572-99.39%265-97.27%1.67K-47.04%153.5K-77.08%16.49K-60.31%32.85K-49.61%43.19K
Other net income (expense) 59.12%-8.76K-849.79%-59.61K53.22%-5.32K-510.91%-29.57K-125.85%-3.3K-659.21%-21.43K71.13%-6.28K-210.07%-11.36K-40.28%-4.84K246.76%12.75K
Gain on sale of security 59.12%-8.76K-183.29%-59.61K53.22%-5.32K-510.91%-29.57K-63.28%-3.3K-659.21%-21.43K3.22%-21.04K-210.07%-11.36K-40.28%-4.84K76.77%-2.02K
Other non- operating income (expenses) --------------------------14.77K--0------14.77K
Income before tax -38.98%-2.25M-16.46%-7.18M-131.63%-2.23M-4.87%-1.75M14.56%-1.59M3.65%-1.62M26.33%-6.17M44.08%-962.05K15.96%-1.67M20.27%-1.86M
Income tax 0.00%800000.00%8000.00%800000.00%800
Net income -38.98%-2.25M-16.46%-7.19M-131.63%-2.23M-4.87%-1.75M14.55%-1.59M3.65%-1.62M26.32%-6.17M44.08%-962.05K15.96%-1.67M20.26%-1.86M
Net income continuous Operations -38.98%-2.25M-16.46%-7.19M-131.63%-2.23M-4.87%-1.75M14.55%-1.59M3.65%-1.62M26.32%-6.17M44.08%-962.05K15.96%-1.67M20.26%-1.86M
Minority interest income
Net income attributable to the parent company -38.98%-2.25M-16.46%-7.19M-131.63%-2.23M-4.87%-1.75M14.55%-1.59M3.65%-1.62M26.32%-6.17M44.08%-962.05K15.96%-1.67M20.26%-1.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -38.98%-2.25M-16.46%-7.19M-131.63%-2.23M-4.87%-1.75M14.55%-1.59M3.65%-1.62M26.32%-6.17M44.08%-962.05K15.96%-1.67M20.26%-1.86M
Basic earnings per share 41.67%-0.2834.20%-1.27-10.34%-0.3251.92%-0.2548.28%-0.311.11%-0.4834.13%-1.9348.21%-0.2923.53%-0.5229.27%-0.58
Diluted earnings per share 41.67%-0.2834.20%-1.27-10.34%-0.3251.92%-0.2548.28%-0.311.11%-0.4834.13%-1.9348.21%-0.2923.53%-0.5229.27%-0.58
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +20.00%
Sample Name
Sample Code
 +12.40%
Sample Name
Sample Code
 +11.01%
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+8.22%
5
United States Oil Fund LP
USO
+7.03%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.20%
Sample Name
Sample Code
 +18.16%
Sample Name
Sample Code
 +12.05%
4
KE Holdings
BEKE
+10.61%
5
ASE Technology
ASX
+8.36%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -